Mito-So
| Catalog Number | BL-M001032 |
| CAS Number | 2315262-16-7 |
| Description | Mito-So, an advanced mitochondrial-targeted antioxidant formulation, is a crucial therapeutic intervention employed in combating the pathophysiological complexities of neurodegenerative disorders and other pathological states fueled by heightened oxidative burden. Its paramount role lies in shielding the intricate mitochondrial organelles from degenerative alterations, thereby bolstering the overall cellular functionality and resilience against oxidative imbalance. |
 | |
| IUPAC Name | (3-(2-((4-(((((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)carbamoyl)oxy)methyl)-2-oxo-2H-chromen-7-yl)(methyl)amino)acetamido)propyl)triphenylphosphonium 2,2,2-trifluoroacetate |
| Synonyms | Mito-Caged Sphingosine; N2-{4-[({[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl]carbamoyl}oxy)methyl]-2-oxo-2H-chromen-7-yl}-N2-methyl-N-[3-(triphenylphosphonio)propyl]glycinamide trifluoroacetate |
| Molecular Weight | 1004.12 |
| Molecular Formula | C55H69F3N3O9P |
| Purity | >99% |
| Solubility | Soluble in Chloroform, Methanol, Ammonium Hydroxide |
| Appearance | Yellowish to Orange Solid |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 65.79%, H 6.93%, F 5.68%, N 4.18%, O 14.34%, P 3.08% |
| Canonical SMILES | CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)OCC1=CC(=O)OC2C=C(C=CC1=2)N(C)CC(=O)NCCC[P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[O-]C(=O)C(F)(F)F |
| InChI | InChI=1S/C53H68N3O7P.C2HF3O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-24-32-49(58)48(40-57)55-53(61)62-41-42-37-52(60)63-50-38-43(33-34-47(42)50)56(2)39-51(59)54-35-25-36-64(44-26-18-15-19-27-44,45-28-20-16-21-29-45)46-30-22-17-23-31-46;3-2(4,5)1(6)7/h15-24,26-34,37-38,48-49,57-58H,3-14,25,35-36,39-41H2,1-2H3,(H-,54,55,59,61);(H,6,7)/b32-24+;/t48-,49+;/m0./s1 |
| InChI Key | CJHOGQDIMUZBHZ-FFLLUZMISA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry